BENEFIT Study: results of interim analysis of a Pan-European observational study to evaluate real-world effectiveness of SB4 following transition from originator etanercept (ETN) in patients with rheumatoid arthritis (RA) or axial sponyloarthritis (axSpA)

Autor: Krüger, Klaus, Zinke, Silke, Karberg, Kirsten, Freudensprung, Ulrich, Rezk, Mourad Farouk, Addison, Janet

Publikováno v: 46. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 32. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder-und Jugendrheumatologie (GKJR); 20180919-20180922; Mannheim; DOCEV.27 /20190205/

Background: SB4, a biosimilar to the reference ETN, received EU marketing authorisation in January 2016, based on the totality of evidence from pre-clinical and clinical Phase I and III studies that demonstrated similar efficacy, bioequivalence, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7c8518278a65cf3755389cddb014a8
http://nbn-resolving.de/urn:nbn:de:0183-18dgrh0776

Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe

Autor: Thakur, Kunal, Biberger, Anna, Handrich, Alexandra, Rezk, Mourad Farouk

Publikováno v: Rheumatology and Therapy. 3:365-365

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9093342b4c6e65f045a7119c19e16c06
https://doi.org/10.1007/s40744-016-0045-z

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe.

Autor: Thakur K; Biogen International GmbH, Zug, Switzerland. kunal.thakur@biogen.com., Biberger A; Kantar Health, Munich, Germany., Handrich A; Biogen International GmbH, Zug, Switzerland., Rezk MF; Biogen International GmbH, Zug, Switzerland.

Publikováno v: Rheumatology and therapy [Rheumatol Ther] 2016 Dec; Vol. 3 (2), pp. 245-256. Date of Electronic Publication: 2016 Nov 05.